The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles
References (644)
- et al.
The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation
Neuropeptides
(1997) - et al.
Septide and neurokinin A are high affinity ligands on the NK1 receptor: evidence from homologous versus heterologous binding analysis
FEBS Letters
(1996) - et al.
The dual nature of the tachykinin NK1 receptor
Trends Pharmacol Sci
(1997) The mammalian tachykinin receptors
Gen Pharmac
(1995)- et al.
Biochemical characterization and autoradiographic localization of central SP receptors using [1251]physalaemin
Brain Res
(1985) - et al.
Pharmacological characterization and autoradiographic characterization of substance P receptors in guinea-pig brain
Peptides
(1986) - et al.
A comparative autoradiographic study of the distributions of substance P and eledoisin binding sites in rat brain
Brain Res
(1986) - et al.
Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain
Peptides
(1988) - et al.
Distribution of the substance P (NK1) receptor in the central nervous system
Mol Brain Res
(1993) - et al.
Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra
Neuroscience
(1995)
Increased level of NK1 tachykinin receptor gene expression during early postnatal development of rat brain
Neuroscience
(1996)
Mismatches between neurotransmitter and receptor localizations in brain: observations and implications
Neuroscience
(1987)
Modulation of the rat mesolimbic dopamine pathway by neurokinins
Behav Brain Res
(1992)
Chromodachryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbils
Eur J Pharmacol
(1994)
Pharmacological characterization of grooming induced by a selective NK1 tachykinin receptor agonist
Brain Res
(1995)
Reduction of substance P after chronic antidepressant treatment in the striatum, substantia nigra and amygdala of the rat
Brain Res
(1996)
Intranigral stimulation of oral movements by [Pro9]substance P a NK1 receptor agonist, is enhanced in chronically neuroleptic-treated rats
Behav Brain Research
(1993)
RP 67,580, a selective antagonist of NK1 receptors modifies some of the naloxone precipitated morphine withdrawal signs in rats
Neurosci Letters
(1993)
Substance P is involved in the sensitization of the acoustic startle response by footshocks in rats
Behav Brain Res
(1994)
Evidence that SP is utilized in medial amygdaloid facilitation of defensive rage behaviour in the cat
Brain Res
(1993)
Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behaviour in mice
Eur J Pharmacol
(1996)
The substance P (NK1) receptor antagonist (±)CP 96345 causes sedation and motor impairment of Swiss albino mice in the black-and-white box behavioral paradigm
Neurosci Letters
(1992)
Trophic effects of various neuropeptides on the cultured ventral spinal cord of rat embryo
Neurosci Letters
(1989)
Tachykinins protect chlinergic neurons from quinolinic acid excitotoxicity in striatal cultures
Brain Res
(1996)
Increased level of NK1 tachykinin receptor gene expression during early postnatal development of rat brain
Neuroscience
(1996)
Receptor-mediated specific biological activity of a β-amyloid protein fragment for NK1 substance P receptors
Bochem Biophys Res Comm
(1993)
Amyloid β protein substituent peptides do not interact with the SP receptor expressed in cultured cells
Mol Brain Res
(1991)
Interaction of amyloid β protein (25–35) with tachykinin receptors
Neuropeptides
(1992)
Cellular MTT reduction distinguishes the mechanism of action of β-amyloid from that of tachykinin receptor peptides
Neuropeptides
(1996)
Substance P stimulates IL-1 production by astrocytes via intracellular calcium
Brain Res
(1992)
Substance P immunoreactive astrocytes are present in multiple sclerosis plaques
Brain Res
(1989)
Functional Substance P receptors on a human astrocytoma cell line (U 373 MG)
Brain Res
(1989)
Different susceptibility to NK1 receptor antagonists of substance P and septide-induced IL-6 release from U373 MG human astrocytoma cell line
Neurosci Letters
(1994)
Role of NK1 receptor in central cardiovascular regulation in rats: studies on a novel nonpeptide antagonist, CP 96345, of substance P NK1 receptor
Regul Peptides
(1993)
In vivo release of substance P in nucleus tractus solitarius increases during hypoxia
Neurosci Letters
(1986)
Effect of substance P on cardiovascular regulation in the rabbit
J Autonom Nervous System
(1995)
Tachykinins and central respiratory activity: an in vitro study on the newborn rat
Eur J Pharmacol
(1996)
Distribution of six neuropeptides in the nucleus tractus solitarii of the rat: an immunohistochemical analysis
Neuroscience
(1984)
Autoradiographic localization of substance P receptors in rat medulla: effect of vagotomy and nodose ganglionectomy
Neuroscience
(1984)
Association of substance P and its receptor with efferent neurons projecting to the greater curvature of the rat stomach
J Autonom Nervous System
(1996)
Evidence that SP is a neurotransmitter of baro- and chemoreceptor afferents in nucleus tractus solitarius
Brain Res
(1980)
Up-regulation of SP binding sites in the vagus nerve projection area of the cat brainstem after nodosectomy
Effects of tachykinins on identified dorsal vagal neurons: an electrophysiological study in vitro
Neuroscience
(1996)
Antiemetic profile of a nonpeptide neurokinin NK1 receptor antagonist, CP 99994 in ferrets
Eur J Pharmacol
(1993)
The tachykinin NK1 receptor antagonist, CP 99994 attenuates cisplatin-induced emesis in the ferret
Eur J Pharmacol
(1993)
Discussion of nomenclature for tachykinins and tachykinin receptors
Molecular characterization of a functional cDNA for rat receptor
J Biol Chem
(1989)
Molecular characterization of a functional cDNA encoding the rat substance P receptor
Science
(1990)
Pharmacological profile of a tachykinin antagonist, spantide, as examined on rat spinal cord motorneurones
Br J Pharmacol
(1990)
Tachykinin NK1 receptor ligands show two distinct pharmacological profiles in rabbit iris sphincter
Br J Pharmacol
(1994)
Cited by (270)
The Efficacy of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Phase 3 Randomized Placebo-Controlled Clinical Trial
2024, Clinical Gastroenterology and HepatologyTachykinins and the potential causal factors for post-COVID-19 condition
2023, The Lancet MicrobePruritus in Dermatology: Part 1 — General Concepts and Pruritogens
2023, Actas Dermo-SifiliograficasGastrointestinal inflammation plays a critical role in chemotherapy-induced nausea and vomiting
2022, European Journal of Pharmacology
Copyright © 1998 Published by Elsevier Ltd.